Estalis Sequi

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Estradiol 4.33mg equivalent to 50 µg/24h oestradiol; Estradiol hemihydrate 0.62mg equivalent to oestradiol 50 µg/24 hours;  ; Norethisterone acetate 2.7mg equivalent to norethisterone acetate 140 µg/24 hours;  

Disponible desde:

Novartis New Zealand Ltd

Designación común internacional (DCI):

Estradiol 4.33 mg (equivalent to 50 µg/24h oestradiol)

Dosis:

50 + 50/140

formulario farmacéutico:

Transdermal patch

Composición:

Active: Estradiol 4.33mg equivalent to 50 µg/24h oestradiol Excipient: 1,3-Butylene glycol Acrylic adhesive Bentonite Dipropylene glycol Ethylenevinylacetate copolymer Lecithin Liquid paraffin Oleic acid Polyisobutylene Synthetic adhesive Active: Estradiol hemihydrate 0.62mg equivalent to oestradiol 50 µg/24 hours   Norethisterone acetate 2.7mg equivalent to norethisterone acetate 140 µg/24 hours   Excipient: Acrylic adhesive Dipropylene glycol Oleic acid Povidone Silicone adhesive

Unidades en paquete:

Sachet, aluminium foil, laminate paper/PE/Al/PE, 8 patches

clase:

Prescription

tipo de receta:

Prescription

Fabricado por:

NV Organon

Resumen del producto:

Package - Contents - Shelf Life: Sachet, aluminium foil, laminate paper/PE/Al/PE - 8 patches - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 6 months opened stored at or below 25°C

Fecha de autorización:

2002-07-12